Balter Invenomic Fund Probability of Future Mutual Fund Price Finishing Over 16.93

BIVRX Fund  USD 16.94  0.06  0.36%   
Balter Invenomic's future price is the expected price of Balter Invenomic instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Balter Invenomic Fund performance during a given time horizon utilizing its historical volatility. Check out Balter Invenomic Backtesting, Portfolio Optimization, Balter Invenomic Correlation, Balter Invenomic Hype Analysis, Balter Invenomic Volatility, Balter Invenomic History as well as Balter Invenomic Performance.
  
Please specify Balter Invenomic's target price for which you would like Balter Invenomic odds to be computed.

Balter Invenomic Target Price Odds to finish over 16.93

The tendency of Balter Mutual Fund price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 16.93  in 90 days
 16.94 90 days 16.93 
about 65.81
Based on a normal probability distribution, the odds of Balter Invenomic to stay above $ 16.93  in 90 days from now is about 65.81 (This Balter Invenomic Fund probability density function shows the probability of Balter Mutual Fund to fall within a particular range of prices over 90 days) . Probability of Balter Invenomic price to stay between $ 16.93  and its current price of $16.94 at the end of the 90-day period is about 1.37 .
Assuming the 90 days horizon Balter Invenomic Fund has a beta of -0.094 suggesting as returns on the benchmark increase, returns on holding Balter Invenomic are expected to decrease at a much lower rate. During a bear market, however, Balter Invenomic Fund is likely to outperform the market. Additionally Balter Invenomic Fund has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Balter Invenomic Price Density   
       Price  

Predictive Modules for Balter Invenomic

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Balter Invenomic. Regardless of method or technology, however, to accurately forecast the mutual fund market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the mutual fund market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
16.3316.9417.55
Details
Intrinsic
Valuation
LowRealHigh
15.2715.8818.63
Details
Naive
Forecast
LowNextHigh
16.1416.7417.35
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
16.8616.9216.98
Details

Balter Invenomic Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Balter Invenomic is not an exception. The market had few large corrections towards the Balter Invenomic's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Balter Invenomic Fund, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Balter Invenomic within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.03
β
Beta against Dow Jones-0.09
σ
Overall volatility
0.27
Ir
Information ratio -0.26

Balter Invenomic Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Balter Invenomic for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Balter Invenomic can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Balter Invenomic generated a negative expected return over the last 90 days
The fund holds about 70.47% of its assets under management (AUM) in cash

Balter Invenomic Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Balter Mutual Fund often depends not only on the future outlook of the current and potential Balter Invenomic's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Balter Invenomic's indicators that are reflective of the short sentiment are summarized in the table below.

Balter Invenomic Technical Analysis

Balter Invenomic's future price can be derived by breaking down and analyzing its technical indicators over time. Balter Mutual Fund technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Balter Invenomic Fund. In general, you should focus on analyzing Balter Mutual Fund price patterns and their correlations with different microeconomic environments and drivers.

Balter Invenomic Predictive Forecast Models

Balter Invenomic's time-series forecasting models is one of many Balter Invenomic's mutual fund analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Balter Invenomic's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the mutual fund market movement and maximize returns from investment trading.

Things to note about Balter Invenomic

Checking the ongoing alerts about Balter Invenomic for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Balter Invenomic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Balter Invenomic generated a negative expected return over the last 90 days
The fund holds about 70.47% of its assets under management (AUM) in cash

Other Information on Investing in Balter Mutual Fund

Balter Invenomic financial ratios help investors to determine whether Balter Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balter with respect to the benefits of owning Balter Invenomic security.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years